Ranibizumab ophthalmic Alternatives Compared
| Ranibizumab ophthalmic | Izervay (avacincaptad pegol) | Eylea (aflibercept) |
|
|---|
| Ranibizumab ophthalmic | Izervay (avacincaptad pegol) | Eylea (aflibercept) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Macular Degeneration, Myopic Choroidal Neovascularization, Diabetic Retinopathy, Diabetic Macular Edema, Macular Edema, Macular Edema Following Retinal Vein Occlusion, Retinopathy... View more |
Prescription only
Prescribed for Macular Degeneration, Geographic Atrophy. Izervay may also be used for purposes not listed in this medication guide. |
Prescription only
Eylea and Eylea HD both contain aflibercept and are VEGF (vascular endothelial growth factor) inhibitors that used to treat retinal eye diseases that may affect your vision. These include neovascular... View more |
Related suggestions Macular Degeneration
|
|||||||||||||||
| More about Ranibizumab ophthalmic | More about Izervay (avacincaptad pegol) | More about Eylea (aflibercept) | ||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Ranibizumab ophthalmic has an average rating of 6.6 out of 10 from a total of 18 ratings on Drugs.com. 61% of reviewers reported a positive effect, while 22% reported a negative effect. |
Izervay has an average rating of 9.0 out of 10 from a total of 4 ratings on Drugs.com. 75% of reviewers reported a positive effect, while 0% reported a negative effect. |
Eylea has an average rating of 7.1 out of 10 from a total of 74 ratings on Drugs.com. 65% of reviewers reported a positive effect, while 19% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||
|
View all Ranibizumab ophthalmic side effects |
View all Izervay side effects |
View all Eylea side effects |
||||||||||||||||
| Drug Class | ||||||||||||||||||
| Generic Availability | ||||||||||||||||||
|
N/A |
N/A |
|||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Izervay prices |
View all Eylea prices |
||||||||||||||||
| Dosage Forms | ||||||||||||||||||
|
N/A |
|
|
||||||||||||||||
| Brand Names | ||||||||||||||||||
| Byooviz, Cimerli, Lucentis, Susvimo |
N/A |
Other aflibercept brands include: Ahzantive, Enzeevu, Eylea HD, Opuviz, Pavblu, Yesafili | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||
|
216 hours |
288 hours |
144 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 2 drugs are known to interact with Ranibizumab ophthalmic:
|
No known drug interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
A total of 1 drugs are known to interact with Eylea:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | ||||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| More Information | ||||||||||||||||||
| Patient Resources | ||||||||||||||||||
| Professional Resources | ||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Vabysmo
Vabysmo eye injection is used to treat eye diseases neovascular (wet) age-related macular ...
Eylea
Eylea is used to treat neovascular (wet) age-related macular degeneration (AMD), macular edema ...
Izervay
Izervay (avacincaptad pegol) is used for treating geographic atrophy (GA) due to age-related ...
Syfovre
Syfovre (pegcetacoplan) treatment for geographic atrophy (GA) a form of dry age-related macular ...
Eylea HD
Eylea HD is used to treat neovascular (wet) age-related macular degeneration (AMD), diabetic ...
Lucentis
Lucentis is used to treat the wet form of age-related macular degeneration. Learn about side ...
Pavblu
Pavblu (aflibercept-ayyh) is a biosimilar to Eylea that may be used to treat the following eye ...
Yesafili
Yesafili (aflibercept-jbvf) is an interchangeable biosimilar to Eylea that may be given by ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.